Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis-Reference-Cited by-同舟云学术

Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis

Published:2012-10-16 Issue:2 Volume:270 Page:641-646
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Graupp M.,Gugatschka M.,Kiesler K.,Reckenzaun E.,Hammer G.,Friedrich G.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://link.springer.com/content/pdf/10.1007/s00405-012-2221-2.pdf

Reference23 articles.

1. Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54:219–225

2. Derkay CS, Darrow DH (2006) Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 115:1–11

3. Derkay CS, Wiatrak B (2008) Recurrent respiratory papillomatosis: a review. Laryngoscope 118:1236–1247

4. Cundy KC (1999) Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 36:127–143

5. Gillen D (2011) Direct healthcare professional communication regarding serious adverse reactions following off-label use of vistide. http://www.cbg-meb.nl/NR/rdonlyres/FFB51936-EC22-4180-A213-9E907F06A774/0/VistideDHPCletterJanuary2011.pdf . Accessed 01 Dec 2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systematic review and indirect meta-analysis;European Archives of Oto-Rhino-Laryngology;2023-10-13

2. Intralesional Cidofovir: A Systematic Review of Administration Protocols and Long-term Recurrence Rates in Adult and Juvenile Recurrent Respiratory Papillomatosis;Journal of Voice;2023-08

3. Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience;Head & Neck;2023-02-25

4. Recurrent Laryngeal Papillomatosis: A Laser CO2 Surgery and Bevacizumab Intralesional Injection as Adjuvant Therapy;An International Journal of Otorhinolaryngology Clinics;2022-04-21

5. Recurrent Respiratory Papillomatosis;Cummings Pediatric Otolaryngology;2021